Last updated on February 2019

Use of Clobazam for Epilepsy and Anxiety


Brief description of study

This study is an open label, adjunctive, proof of concept, pilot clinical trial. Pediatric patients with epilepsy and clinically significant anxiety will be recruited and if enrolled will receive active treatment, involving flexible dose titration of clobazam and will be monitored for a period of four months. The study will be monitored and overseen by the Johns Hopkins Hospital Institutional Review Board.

Clinical Study Identifier: NCT03371836

Find a site near you

Start Over

Kennedy Krieger Institute

Baltimore, MD United States
  Connect »